← Leaderboards
Catherine Marinac
University Of California, San Diego
$1,187,243
Attributed
$1,187,243
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $400.3K · FY2014–23$500K$375K$250K$125K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$1,187,243 · 4
By mechanism
K22$576,720 · 1
R21$452,690 · 1
F32$93,795 · 1
F31$64,038 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California, San Diego
Same institution · by research overlap
- Partho Ghosh$14,796,209
- Victor Nizet$31,303,620
- Lisa Anne Cadmusbertram$3,963,828
- Leslie A Crews$1,884,271
- Madepalli Krishnappa Lakshmana$3,132,279
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsAreaCancer RiskSerumHigh RiskEnergy BalanceInnovationPositioning AttributeClinically RelevantDisease ProgressionPrevention StrategyMetabolic PathwayProgramsMultiple MyelomaBaseCellsInterceptInterestComplementDesignCareerCancer PreventionCohortBone Marrow
Grant awards (9)
Prolonged Nightly Fasting as a Behavioral Intervention for Obesity Reduction and the Prevention of Progression in Precursor Multiple Myeloma$244,652
R21 · FY2023 · CA · contact PI
Prolonged Nightly Fasting as a Behavioral Intervention for Obesity Reduction and the Prevention of Progression in Precursor Multiple Myeloma$208,038
R21 · FY2022 · CA · contact PI
Repurposing Metformin for the Prevention of Disease Progression in Precursor Multiple Myeloma$192,240
K22 · FY2022 · CA · contact PI
Repurposing Metformin for the Prevention of Disease Progression in Precursor Multiple Myeloma$192,240
K22 · FY2021 · CA · contact PI
Repurposing Metformin for the Prevention of Disease Progression in Precursor Multiple Myeloma$192,240
K22 · FY2020 · CA · contact PI
Obesity, Molecular Biomarkers, and Multiple Myeloma Prognosis$32,441
F32 · FY2019 · CA · contact PI
Obesity, Molecular Biomarkers, and Multiple Myeloma Prognosis$61,354
F32 · FY2018 · CA · contact PI
Prolonged Overnight Fasting for Reducing Breast Cancer Risk$29,696
F31 · FY2015 · CA · contact PI
Prolonged Overnight Fasting for Reducing Breast Cancer Risk$34,342
F31 · FY2014 · CA · contact PI